Company Data

Erasca Inc.

Ticker
ERAS
Current Price
$1.46 -3.31%
Market Cap
$412.8M
Price Target
Refer to Report
Volume
807.5K
52wk Range
$1.45 - $3.45
Advanced Market Data

Overview

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy